MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.

Also called NCT03234348

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 151 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03234348
Main results
  • Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial Circulation, 2019-12-03 DOI, PubMed 31553204
Other papers using this trial's data
  • Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2020-12-04 DOI, PubMed 32310130

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03234348. Randomized; double masking; primary purpose treatment. Start 2017-07-01 (actual); primary completion 2019-06-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction
Acronym
MAGSTEMI
Condition
Acute Coronary Syndrome
Condition
ST Segment Elevation Myocardial Infarction
Condition
Stent
Lead sponsor
Hospital Clinic of Barcelona (class: other)
Collaborator
Spanish Society of Cardiology (class: other)

Record details

Record id
cardio:ct-nct03234348
Content hash
0a415512bbad9ed191c1a2e717cc19359d05578fa6940f817a56ad4ae653cbe4